Stock to Watch: Else Nutrition Holdings (TSXV:BABY) (OTCPK:BABYF)

Else Nutrition

Analysts have been taking notice of Else Nutrition Holdings Inc. (TSXV:BABY) (OTCPK:BABYF) and are giving a “BUY” recommendation to the food and nutrition company that has developed the first 100% plant-based infant nutritional formula.

Else Nutrition


Else Nutrition Holdings Inc. (TSXV:BABY) (OTCPK:BABYF) currently has a “BUY” recommendation from TradingView’s technical analysis, which weighs multiple market indicators such as moving averages, oscillators, and pivots to provide an assessment of the stock’s price and direction. 

While the overall recommendation is a “BUY”, the moving averages indicators have been awarded a “STRONG BUY”. This indicates that BABY shares are trending towards even greater growth, which also bears out when looking at the stock’s forecast.

Enter Your E-mail Address To Subscribe

* indicates required

Else Nutrition

According to TradingView’s forecast, Else Nutrition Holdings’ (TSXV:BABY) (OTCPK:BABYF) has a target price of $0.90, which it is projected to reach in late March 2020. This represents 94.5% growth from its current position at $0.47.

Else Nutrition’s Market Position

Else Nutrition Holdings’ (TSXV:BABY) (OTCPK:BABYF) 100% plant-based, non-soy alternative to dairy-based baby formula is the first of its kind on the market. It’s free of GMOs, pesticides, hormones, antibiotics, gluten, and phytoestrogens, and has no externally added macro-nutrients. Made from almonds and buckwheat, it is a healthier and more natural option for toddlers (12-36 months).

According to Hexa Research, the global market for formula will exceed $90 billion USD by 2025 with a CAGR of 9.35%. This growth is in part by the introduction of formulas with added nutrition, such as the one offered by Else.

More specifically, the global organic baby food market is projected to grow from $5.95 billion last year to $11 billion by 2024, with a CAGR of 11%. As research shows that dairy and soy allergens are incredibly common among children under the age of five, Else Nutrition Holdings’ (TSXV:BABY) (OTCPK:BABYF) has unparalleled access to a sizable share of the market.

Share Information and Performance

Else Nutrition Holdings’ (TSXV:BABY) (OTCPK:BABYF) currently has 67.14 million shares issued and outstanding. BABY stock achieved a 52-week high of $0.75 in mid-June and as of October 30 is selling at $0.47 on the TSX Venture Exchange. 

The company expects US sales of its toddler formula and kids’ nutritional drinks to begin in the spring of 2020. It will be fascinating to watch how Wall Street reacts to these product launches when it’s already being so bullish on BABY.

Featured image: Else Nutrition

Please See Disclaimer

If You Liked This Article Click To Share


1) The author of the Article, or members of the author’s immediate household or family, do not own any securities of the companies set forth in this Article. The author determined which companies would be included in this article based on research and understanding of the sector.

2) The Article was issued on behalf of a third party, Else Nutrition Holdings Inc. Market Jar Media Inc. expects to receive the following amounts from Native Ads Inc. in the amount of one hundred twelve thousand dollars USD for 15 campaign days (10 business days).

3) Statements and opinions expressed are the opinions of the author and not Market Jar Media Inc., its directors or officers. The author is wholly responsible for the validity of the statements. The author was not paid by Market Jar Media Inc. for this Article. Market Jar Media Inc. was not paid by the author to publish or syndicate this Article. The information provided above is for informational purposes only and is not a recommendation to buy or sell any security. Market Jar Media Inc. requires contributing authors to disclose any shareholdings in, or economic relationships with, companies that they write about. Market Jar Media Inc. relies upon the authors to accurately provide this information and Market Jar Media Inc. has no means of verifying its accuracy.

4) The Article does not constitute investment advice. Each reader is encouraged to consult with his or her individual financial professional and any action a reader takes as a result of the information presented here is his or her own responsibility. By opening this page, each reader accepts and agrees to Market Jar Media Inc.'s terms of use and full legal disclaimer as set forth here. This Article is not a solicitation for investment. Market Jar Media Inc. does not render general or specific investment advice and the information on should not be considered a recommendation to buy or sell any security. Market Jar Media Inc. does not endorse or recommend the business, products, services or securities of any company mentioned on

5) Market Jar Media Inc. and its respective directors, officers and employees hold no shares for any company mentioned in the Article.